Search
Now showing items 1-10 of 31
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
Kroenke, Jan et al. (2013)
Wissenschaftlicher Artikel
Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia
Schlenk, Richard F.; Döhner, Hartmut (2013)
Wissenschaftlicher Artikel
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AMLStudy Group (AMLSG)
Paschka, Peter et al. (2013)
Wissenschaftlicher Artikel
BRAF mutations in chronic lymphocytic leukemia
Jebaraj, Billy Michael Chelliah et al. (2013)
Wissenschaftlicher Artikel
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia
Hopfinger, Georg et al. (2013)
Wissenschaftlicher Artikel
Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
Kampa-Schittenhelm, Kerstin Maria et al. (2013)
Wissenschaftlicher Artikel
Telomere length in mantle cell lymphoma
Jebaraj, Billy Michael Chelliah et al. (2013)
Wissenschaftlicher Artikel
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, Francesco et al. (2013)
Wissenschaftlicher Artikel
FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors
Neumann, Martin et al. (2013)
Wissenschaftlicher Artikel
A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia
Mueller-Tidow, Carsten et al. (2013)
Wissenschaftlicher Artikel